CRISPR Eradicates Latent HIV-1, Offering Hope of “Functional Cures” – Genetic Engineering & Biotechnology News
Drug Target Review |
CRISPR Eradicates Latent HIV-1, Offering Hope of "Functional Cures"
Genetic Engineering & Biotechnology News Scientists in Japan have used CRISPR-Cas9 technology to stop human immunodeficiency virus type 1 (HIV-1) replication in latently infected T cells that can't be controlled using existing drug treatments. The gene-editing approach effectively disrupts … CRISPR used to destroy the regulatory genes of HIV |
